International note: Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in Argentina

Medical and Pediatric Oncology

Volumn 41, Issue 5, 2003, Pages 488-490

  Chantada, Guillermo ^a   Casak, Sandra ^a   Alderete, Daniel ^b   Zubizarreta, Pedro ^a   Gallo, Guillermo ^a   Sackmann Muriel, Federico ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b NONE

Author keywords

BFM; Childhood lymphomas; NHL in Argentina

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; METHOTREXATE; PREDNISONE; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; DAUNORUBICIN; PVDA PROTOCOL;

ARGENTINA; B CELL LYMPHOMA; BLOOD TOXICITY; BRAIN TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CONFERENCE PAPER; DRUG FATALITY; DRUG FEVER; DRUG MEGADOSE; HUMAN; HUMAN CELL; INFANT; LIVER TOXICITY; MAJOR CLINICAL STUDY; NEUTROPENIA; NEWBORN; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SECOND LOOK SURGERY; SURVIVAL TIME; TREATMENT OUTCOME; ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; MALE; MAXIMUM TOLERATED DOSE; MORTALITY; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARGENTINA; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MAXIMUM TOLERATED DOSE; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0141960312     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10288     Document Type: Conference Paper

References (8)

1. Chantada G, Felice M, Zubizarreta PA, et al. Results of a BFM-based for the treatment of childhood B-non-Hodgkin's lymphoma in Argentina. Med Pediatr Oncol 1997;28:333-341.
2. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood E-cell neoplasms with tailored intensification of therapy: A report of the Berlin Frankfurt Munster Group trial NHL-BFM-90. Blood 1999;94:3294-3306.
3. Murphy S. Current concepts in cancer. Childhood non-Hodgkin's lymphoma. N Eng J Med 1997;297:75-80.
4. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Slat Assoc 1958;53:457-481.
5. Sackmann-Muriel F, Felice M, Zubizarreta P, et al. Treatment results of childhood acute lymphoblastic leukemia with a modified ALL-BFM-90 protocol. Lack of improvement in high-risk group. Leuk Res 1999;23:331-340.
6. Reiter A, Schrappe M, Parwaresch R, et al. Non Hodgkin's lymphoma of childhood and adolescence. Results of a treatment stratified for biologic subtypes and stage: A report of the BFM group. J Clin Oncol 1995;13:359-372.
7. Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Society of Pediatric Oncology of a randomized trial of 216 children. J Clin Oncol 1991;9:123-132.
8. 2 is not as efficacious for treatment of advanced B-cell neoplasms of childhood and adolescence than 24-hour I.V. infusion although less toxic. Interim result of trial NHL-BFM-95. Blood 2001;98:246 (abstract).